Explore the essentials of device law and regulation and gain a comprehensive understanding of the administrative agencies that impact this industry. Learn about registration and listing procedures, elements of conducting clinical investigations, Premarket Approval Application, advertising and promotion, compliance, enforcement, and related issues. Case studies, hypotheticals, and ample time for Q&A are provided.


Agenda Highlights

  • Overview of the organizational structure of the FDA
  • FDA’s regulatory process for medical devices
  • How to prepare a successful 510(k) submission
  • Registration and listing requirements
  • Elements of conducting clinical investigations
  • Premarket Approval Application (PMA) and approval process
  • Post-marketing requirements
  • FDA’s enforcement tools and procedures
  • Advertising and promotion requirements
  • Quality System Regulation (QSR)

Statutes Covered

  • Federal Food, Drug & Cosmetic Act (FD&C Act)
  • 1976 Medical Device Amendment
  • Safe Medical Devices Act of 1990 (SMDA)
  • Mammography Quality Standard Act of 1992 (MQSA)
  • Food and Drug Administration Modernization Act of 1997 (FADAMA)
  • Food and Drug Administration Amendments Act of 2007 (FDAAA)
  • 21st Century Cures Act (2016)
  • Medical Device User Fee Reauthorization Legislation (including Food and Drug Administration Reauthorization Act of 2017 (FDARA))

Attendee Resources

These valuable takeaways will be provided onsite:

Who Should Attend

  • New legal and regulatory professionals
  • Seasoned practitioners new to the topic or wanting a refresher


Industry & Firms

  • +$400 for non-members


  • +$200 for non-members


  • +$200 for non-members


  • +$200 for non-members


  • transcripts required

COVID-19 Update

In light of travel restrictions due to COVID-19 and out of concern for the safety of our community, FDLI will solely be holding its upcoming programs as virtual events. The registration process remains unchanged. FDLI will contact all registrants with more information regarding virtual access closer to each program’s respective event date.

Register Now


Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you in your purchase.

Add This Must-Have Reference to Your Registration

Purchase A Practical Guide to FDA’s Food and Drug Law Regulation, 6th Edition to have an overview of the key legal and regulatory topics at your fingertips.  Order your copy today and it will be shipped directly to your office.

To ensure that FDLI is able to provide you with a seat, materials, and meals, please register for programs at least 48 hours in advance. While onsite registration is available on a “space-available” basis; late registrants are not guaranteed materials or meals.

You can transfer your registration to another person at your organization for no cost by notifying us of the change. If you notify FDLI in writing at least five business days prior to the meeting, you can cancel your registration for a full refund (less a $75 fee). Refunds will be applied against the original form of payment.  

Our event policies are listed here. If you should have any further questions, please contact us at [email protected] or 800-956-6293.


subject to change
Curriculum Advisor: Jeffrey K. Shapiro, Director, Hyman, Phelps & McNamara, PC

Tuesday, April 7

8:30–8:35 AM
FDLI Welcome and Announcements
Khara L. Minter, Assistant Director, Training Programs, FDLI

8:35–9:35 AM
Overview of Medical Device Law and Regulation
McKenzie E. Cato, Associate, Hyman, Phelps & McNamara, PC

9:35–9:50 AM

9:50–11:35 AM
Premarket Notification 510(k) and De Novo Applications
Jeffrey K. Shapiro, Director, Hyman, Phelps & McNamara, PC

11:35 AM–12:35 PM
Lunch Break

12:35–1:35 PM
Registration and Listing
John Johnson, III, Counsel, Shook, Hardy & Bacon LLP

1:35–2:45 PM
Clinical Investigations: Investigational Device Exemption (IDE), Institutional Review Boards (IRBs), and informed Consent
Blake E. Wilson, Senior Associate, Hogan Lovells US LLP

2:45–3:00 PM

3:00–4:00 PM
Clinical Investigations: Sponsor Responsibilities and Compliance Issues
Christina Kuhn, Associate, Covington & Burling LLP
Amy Leiser, Associate, Covington & Burling LLP

4:00–5:00 PM
Premarket Approval Application (PMA); Humanitarian Device Exemption (HDE)
Janice M. Hogan, Partner, Hogan Lovells US LLP



Wednesday, April 8

8:00–8:30 AM
Registration and Continental Breakfast          

8:30–9:30 AM
Manufacturing and Quality System Regulation (QSR)
Allison Fulton
, Partner, Sheppard Mullin Richter & Hampton LLP

9:30–10:40 AM
Post Marketing Issues
Marc J. Scheineson, Partner, Alston & Bird LLP
Benjamin Wolf, Senior Associate, Alston & Bird LLP

10:40–10:55 AM
Networking and Refreshment Break

10:55 AM–12:00 PM
Enforcement and Compliance
Frederick A. Stearns, Partner, Keller & Heckman LLP

12:00–1:00 PM
Networking Lunch

1:00–2:30 PM
Promotion and Advertising
Carolina Wirth,Of Counsel, Arnall Golden Gregory LLP
Genevieve M. Razick, Associate, Arnall Golden Gregory LLP

2:30–2:45 PM
Networking and Refreshment Break

2:45–4:00 PM
Manufacturing and Quality System (QS) Regulation
Cybil Roehrenbeck, Shareholder, Polsinelli PC

4:00–5:00 PM
International Issues
Sarah H. Stec, Senior Counsel, Medical Device Regulatory Law, Johnson & Johnson

5:00 PM



Continuing Legal Education

FDLI applies for CLE credits in Ohio, Pennsylvania, and Virginia. These CLE approvals may also be honored by other states; please check with your bar association for guidance. The CLE credits will be posted as they are granted and you can request to be notified when approval is received.